Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors

AU2026210811A1Pending Publication Date: 2026-08-20REGENERON PHARMACEUTICALS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: AU2026210811
Authority / Receiving Office: AU · AU
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2026-07-31
Publication Date: 2026-08-20

Application Information

Patent Timeline

31 Jul 2026

Application

AU2026210811

20 Aug 2026

Publication

AU2026210811A1

IPC: A61K31/7088; A61P1/16; A61P3/10; C12N15/113; C12Q1/6883

Inventors: SOSINA, OLUKAYODE; AKBARI, PARSA

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Abstract The present disclosure provides methods of treating a subject having a liver disease or type 2 diabetes, and methods of identifying subjects having an increased risk of developing a liver disease or type 2 diabetes. 5 Abstract 5 20 26 21 08 11 31 J ul 2 02 6 2 0 2 6 2 1 0 8 1 1 3 1 J u l 2 0 2 6 5

Need to check novelty before this filing date? Find Prior Art